版本:
中国

BRIEF-Cardiome announces commercial launch of BRINAVESS in Canada

June 12 Cardiome Pharma Corp:

* Cardiome announces commercial launch of Brinavess® (vernakalant hydrochloride) in Canada

* Says product is currently available on Ontario formulary, with a broader launch anticipated in q3 of this year

* Cardiome Pharma Corp says product is currently available on Ontario formulary, with a broader launch anticipated in Q3 of 2017

* Cardiome Pharma Corp- we are ready for sales to commence ahead of our previously guided Q4 timeline. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐